Author:
Hanai Akiko,Ishiguro Hiroshi,Sozu Takashi,Tsuda Moe,Arai Hidenori,Mitani Akira,Tsuboyama Tadao
Funder
Japan Society for the Promotion of Science
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. U.S. Department of Health and Human Services: common terminology criteria for adverse events (CTCAE) version 4.0.
http://www.jcog.jp/doctor/tool/CTCAEv4J_20111217.pdf
2. Gibson RJ, Keefe DM (2006) Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies. Supp Care Cancer 14:890–900
3. Eisenberg P, Figueroa-Vadillo J, Zamora R et al (2003) Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist. Cancer 98:2473–2482
4. Kimura M, Usami E, Yasuda T et al (2007) Analysis of adverse reactions in cancer chemotherapy: constipation occurring with co-administration of anticancer agents and 5-HT_3 antagonists. JSPHCS 33:863–868
5. Takei A, Fukuda Y, Seyama R et al (2008) Nursing support based on the characteristics of adverse reactions to outpatient chemotherapy: an analysis of adverse reactions recorded in patients’ diaries. Ann Gunma Univ Sch Health Sci 29:11–20
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献